Your browser doesn't support javascript.
loading
Hyperglobulinemia predicts increased risk of mortality in primary Sjögren's syndrome: Based on a Chinese multicentre registry.
Zhong, Hui; Wang, Yanhong; Yang, Pingting; Duan, Xinwang; Wang, Yongfu; Xu, Jian; Wu, Lijun; Li, Qin; Kong, Xiaodan; Zhang, Liyun; Li, Xiaomei; Xu, Dong; Li, Mengtao; Zhao, Yan; Zeng, Xiaofeng.
Afiliação
  • Zhong H; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, PR China.
  • Wang Y; Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, PR China.
  • Yang P; Department of Rheumatology and Immunology, The First Affiliated Hospital, China Medical University, Shenyang, PR China.
  • Duan X; Department of Rheumatology and Immunology, The Second Affiliated Hospital of Nanchang University, Nanchang, PR China.
  • Wang Y; Department of Rheumatology, The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia, PR China.
  • Xu J; Department of Rheumatology and Immunology, The First Affiliated Hospital of Kunming Medical University, Kunming, PR China.
  • Wu L; Department of Rheumatology and Immunology, Xinjiang Uygur Autonomous Region People's Hospital, Xinjiang, PR China.
  • Li Q; Department of Rheumatology, The First People's Hospital of Yunnan Province, Kunming, PR China.
  • Kong X; Department of Rheumatology and Immunology, The Second Affiliated Hospital, Dalian Medical University, Dalian, PR China.
  • Zhang L; Department of Rheumatology and Immunology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Shanxi, PR China.
  • Li X; Department of Rheumatology and Immunology, The First Affiliated Hospital of University of Science and Technology of China (Anhui Province Hospital), Anhui, PR China.
  • Xu D; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, PR China.
  • Li M; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, PR China.
  • Zhao Y; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, PR China.
  • Zeng X; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, PR China.
Mod Rheumatol ; 34(1): 137-143, 2023 Dec 22.
Article em En | MEDLINE | ID: mdl-36688590
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Síndrome de Sjogren Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Mod Rheumatol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Síndrome de Sjogren Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Mod Rheumatol Ano de publicação: 2023 Tipo de documento: Article